Janus Henderson Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Janus Henderson Group’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-66,786	Closed	-$2.52M	–	1718
2021 Q1	$2.52M	Buy	+66,786	New	+$1.67M	﹤0.01%	1142

Janus Henderson Group's FPRX Position: Q2 2021 in Review

Janus Henderson Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 66,786 shares — an estimated $2.52M sold.

Janus Henderson Group first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $2.52M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Janus Henderson Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Janus Henderson Group sold 66,786 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $2.52M.
Janus Henderson Group first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Janus Henderson Group's Five Prime Therapeutics, Inc. position peaked at $2.52M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.